TY - JOUR PY - 2009 DA - 2009// TI - U.S. Preventive Services Task Force recommendation statement JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-6-200903170-00008 DO - 10.7326/0003-4819-150-6-200903170-00008 ID - ref1 ER - TY - JOUR AU - Fisher, B. AU - Costantino, J. P. AU - Wickerham, D. L. AU - Redmond, C. K. AU - Kavanah, M. AU - Cronin, W. M. AU - Vogel, V. AU - Robidoux, A. AU - Dimitrov, N. AU - Atkins, J. PY - 1998 DA - 1998// TI - Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.18.1371 DO - 10.1093/jnci/90.18.1371 ID - Fisher1998 ER - TY - JOUR AU - Gail, M. H. AU - Costantino, J. P. AU - Bryant, J. AU - Croyle, R. AU - Freedman, L. AU - Helzlsouer, K. AU - Vogel, V. PY - 1999 DA - 1999// TI - Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.21.1829 DO - 10.1093/jnci/91.21.1829 ID - Gail1999 ER - TY - JOUR AU - Dolan, J. G. PY - 2010 DA - 2010// TI - Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare JO - Patient VL - 3 UR - https://doi.org/10.2165/11539470-000000000-00000 DO - 10.2165/11539470-000000000-00000 ID - Dolan2010 ER - TY - JOUR AU - Guo, J. J. AU - Pandey, S. AU - Doyle, J. AU - Bian, B. AU - Lis, Y. AU - Raisch, D. W. PY - 2010 DA - 2010// TI - A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group JO - Value Health VL - 13 UR - https://doi.org/10.1111/j.1524-4733.2010.00725.x DO - 10.1111/j.1524-4733.2010.00725.x ID - Guo2010 ER - TY - JOUR AU - Holden, W. L. AU - Juhaeri, J. AU - Dai, W. PY - 2003 DA - 2003// TI - Benefit-risk analysis: a proposal using quantitative methods JO - Pharmacoepidemiol Drug Saf VL - 12 UR - https://doi.org/10.1002/pds.887 DO - 10.1002/pds.887 ID - Holden2003 ER - TY - JOUR AU - Lynd, L. D. AU - Najafzadeh, M. AU - Colley, L. AU - Byrne, M. F. AU - Willan, A. R. AU - Sculpher, M. J. AU - Johnson, F. R. AU - Hauber, A. B. PY - 2010 DA - 2010// TI - Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making–a case study of alosetron in irritable bowel syndrome JO - Value Health VL - 13 UR - https://doi.org/10.1111/j.1524-4733.2009.00595.x DO - 10.1111/j.1524-4733.2009.00595.x ID - Lynd2010 ER - TY - JOUR AU - Walter, S. D. AU - Sinclair, J. C. PY - 2009 DA - 2009// TI - Uncertainty in the minimum event risk to justify treatment was evaluated JO - J Clin Epidemiol VL - 62 UR - https://doi.org/10.1016/j.jclinepi.2008.09.017 DO - 10.1016/j.jclinepi.2008.09.017 ID - Walter2009 ER - TY - JOUR AU - O'Neill, R. T. PY - 2008 DA - 2008// TI - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? JO - Drug Inf J VL - 42 ID - O'Neill2008 ER - TY - BOOK PY - 2008 DA - 2008// TI - Reflection paper on benefit-risk assessment methods in the context of the evaluation of marketing authorisation applications of medicinal products for human use ID - ref10 ER - TY - BOOK PY - 2007 DA - 2007// TI - Report of the Committee for Medicinal Products Working Group on Benefit-Risk Assessment Models and Methods ID - ref11 ER - TY - JOUR AU - Laupacis, A. AU - Sackett, D. L. AU - Roberts, R. S. PY - 1988 DA - 1988// TI - An assessment of clinically useful measures of the consequences of treatment JO - N Engl J Med VL - 318 UR - https://doi.org/10.1056/NEJM198806303182605 DO - 10.1056/NEJM198806303182605 ID - Laupacis1988 ER - TY - JOUR AU - Cook, R. J. AU - Sackett, D. L. PY - 1995 DA - 1995// TI - The number needed to treat: a clinically useful measure of treatment effect JO - BMJ VL - 310 UR - https://doi.org/10.1136/bmj.310.6977.452 DO - 10.1136/bmj.310.6977.452 ID - Cook1995 ER - TY - JOUR AU - Gelber, R. D. AU - Goldhirsch, A. AU - Cole, B. F. PY - 1993 DA - 1993// TI - Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group JO - Cancer Treat Rev VL - 19 UR - https://doi.org/10.1016/0305-7372(93)90060-5 DO - 10.1016/0305-7372(93)90060-5 ID - Gelber1993 ER - TY - JOUR AU - Gelber, R. D. AU - Goldhirsch, A. AU - Cole, B. F. AU - Wieand, H. S. AU - Schroeder, G. AU - Krook, J. E. PY - 1996 DA - 1996// TI - A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer JO - J Natl Cancer Inst VL - 88 UR - https://doi.org/10.1093/jnci/88.15.1039 DO - 10.1093/jnci/88.15.1039 ID - Gelber1996 ER - TY - JOUR AU - Mussen, F. AU - Salek, S. AU - Walker, S. PY - 2007 DA - 2007// TI - A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis JO - Pharmacoepidemiol Drug Saf VL - 16 UR - https://doi.org/10.1002/pds.1435 DO - 10.1002/pds.1435 ID - Mussen2007 ER - TY - JOUR AU - Mussen, F. AU - Salek, S. AU - Walker, S. AU - Phillips, L. PY - 2007 DA - 2007// TI - A quantitative approach to benefit-risk assessment of medicines - part 2: the practical application of a new model JO - Pharmacoepidemiol Drug Saf VL - 16 UR - https://doi.org/10.1002/pds.1434 DO - 10.1002/pds.1434 ID - Mussen2007 ER - TY - JOUR AU - Singer, D. E. AU - Albers, G. W. AU - Dalen, J. E. AU - Fang, M. C. AU - Go, A. S. AU - Halperin, J. L. AU - Lip, G. Y. AU - Manning, W. J. PY - 2008 DA - 2008// TI - Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) JO - Chest VL - 133 UR - https://doi.org/10.1378/chest.08-0678 DO - 10.1378/chest.08-0678 ID - Singer2008 ER - TY - JOUR AU - Guyatt, G. H. AU - Sinclair, J. AU - Cook, D. J. AU - Glasziou, P. PY - 1999 DA - 1999// TI - Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.19.1836 DO - 10.1001/jama.281.19.1836 ID - Guyatt1999 ER - TY - JOUR AU - March, J. S. AU - Klee, B. J. AU - Kremer, C. M. PY - 2006 DA - 2006// TI - Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents JO - J Child Adolesc Psychopharmacol VL - 16 UR - https://doi.org/10.1089/cap.2006.16.91 DO - 10.1089/cap.2006.16.91 ID - March2006 ER - TY - JOUR AU - Singh, S. AU - Dolan, J. G. AU - Centor, R. M. PY - 2006 DA - 2006// TI - Optimal management of adults with pharyngitis–a multi-criteria decision analysis JO - BMC Med Inform Decis Mak VL - 6 UR - https://doi.org/10.1186/1472-6947-6-14 DO - 10.1186/1472-6947-6-14 ID - Singh2006 ER - TY - JOUR AU - Elwyn, G. AU - O'Connor, A. AU - Stacey, D. AU - Volk, R. AU - Edwards, A. AU - Coulter, A. AU - Thomson, R. AU - Barratt, A. AU - Barry, M. AU - Bernstein, S. PY - 2006 DA - 2006// TI - Developing a quality criteria framework for patient decision aids: online international Delphi consensus process JO - BMJ VL - 333 UR - https://doi.org/10.1136/bmj.38926.629329.AE DO - 10.1136/bmj.38926.629329.AE ID - Elwyn2006 ER - TY - JOUR AU - Boers, M. AU - Brooks, P. AU - Fries, J. F. AU - Simon, L. S. AU - Strand, V. AU - Tugwell, P. PY - 2010 DA - 2010// TI - A first step to assess harm and benefit in clinical trials in one scale JO - J Clin Epidemiol VL - 63 UR - https://doi.org/10.1016/j.jclinepi.2009.07.002 DO - 10.1016/j.jclinepi.2009.07.002 ID - Boers2010 ER - TY - JOUR AU - Garrison, L. P. AU - Towse, A. AU - Bresnahan, B. W. PY - 2007 DA - 2007// TI - Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis JO - Health Aff (Millwood) VL - 26 UR - https://doi.org/10.1377/hlthaff.26.3.684 DO - 10.1377/hlthaff.26.3.684 ID - Garrison2007 ER - TY - JOUR AU - Ponce, R. A. AU - Bartell, S. M. AU - Wong, E. Y. AU - LaFlamme, D. AU - Carrington, C. AU - Lee, R. C. AU - Patrick, D. L. AU - Faustman, E. M. AU - Bolger, M. PY - 2000 DA - 2000// TI - Use of quality-adjusted life year weights with dose–response models for public health decisions: a case study of the risks and benefits of fish consumption JO - Risk Anal VL - 20 UR - https://doi.org/10.1111/0272-4332.204050 DO - 10.1111/0272-4332.204050 ID - Ponce2000 ER - TY - JOUR AU - Dolan, J. G. PY - 2008 DA - 2008// TI - Shared decision-making–transferring research into practice: the Analytic Hierarchy Process (AHP) JO - Patient Educ Couns VL - 73 UR - https://doi.org/10.1016/j.pec.2008.07.032 DO - 10.1016/j.pec.2008.07.032 ID - Dolan2008 ER - TY - JOUR AU - Holden, W. L. AU - Juhaeri, J. AU - Dai, W. PY - 2003 DA - 2003// TI - Benefit-risk analysis: examples using quantitative methods JO - Pharmacoepidemiol Drug Saf VL - 12 UR - https://doi.org/10.1002/pds.794 DO - 10.1002/pds.794 ID - Holden2003 ER - TY - JOUR AU - Sutton, A. J. AU - Cooper, N. J. AU - Abrams, K. R. AU - Lambert, P. C. AU - Jones, D. R. PY - 2005 DA - 2005// TI - A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty JO - J Clin Epidemiol VL - 58 UR - https://doi.org/10.1016/j.jclinepi.2004.03.015 DO - 10.1016/j.jclinepi.2004.03.015 ID - Sutton2005 ER - TY - JOUR AU - Lynd, L. D. AU - O'Brien, B. J. PY - 2004 DA - 2004// TI - Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis JO - J Clin Epidemiol VL - 57 UR - https://doi.org/10.1016/j.jclinepi.2003.12.012 DO - 10.1016/j.jclinepi.2003.12.012 ID - Lynd2004 ER - TY - JOUR AU - Sherrill, B. AU - Amonkar, M. M. AU - Stein, S. AU - Walker, M. AU - Geyer, C. AU - Cameron, D. PY - 2008 DA - 2008// TI - Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer JO - Br J Cancer VL - 99 UR - https://doi.org/10.1038/sj.bjc.6604501 DO - 10.1038/sj.bjc.6604501 ID - Sherrill2008 ER - TY - JOUR AU - Shakespeare, T. P. AU - Gebski, V. J. AU - Veness, M. J. AU - Simes, J. PY - 2001 DA - 2001// TI - Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)04522-0 DO - 10.1016/S0140-6736(00)04522-0 ID - Shakespeare2001 ER - TY - JOUR AU - Shaffer, M. L. AU - Watterberg, K. L. PY - 2006 DA - 2006// TI - Joint distribution approaches to simultaneously quantifying benefit and risk JO - BMC Med Res Methodol VL - 6 UR - https://doi.org/10.1186/1471-2288-6-48 DO - 10.1186/1471-2288-6-48 ID - Shaffer2006 ER - TY - JOUR AU - Hauber, A. B. AU - Mohamed, A. F. AU - Johnson, F. R. AU - Falvey, H. PY - 2009 DA - 2009// TI - Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents JO - Diabet Med VL - 26 UR - https://doi.org/10.1111/j.1464-5491.2009.02696.x DO - 10.1111/j.1464-5491.2009.02696.x ID - Hauber2009 ER - TY - JOUR AU - Johnson, F. R. AU - Ozdemir, S. AU - Mansfield, C. AU - Hass, S. AU - Miller, D. W. AU - Siegel, C. A. AU - Sands, B. E. PY - 2007 DA - 2007// TI - Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy JO - Gastroenterology VL - 133 UR - https://doi.org/10.1053/j.gastro.2007.04.075 DO - 10.1053/j.gastro.2007.04.075 ID - Johnson2007 ER - TY - JOUR AU - Johnson, F. R. AU - Ozdemir, S. AU - Mansfield, C. AU - Hass, S. AU - Siegel, C. A. AU - Sands, B. E. PY - 2009 DA - 2009// TI - Are adult patients more tolerant of treatment risks than parents of juvenile patients? JO - Risk Anal VL - 29 UR - https://doi.org/10.1111/j.1539-6924.2008.01135.x DO - 10.1111/j.1539-6924.2008.01135.x ID - Johnson2009 ER - TY - JOUR AU - Chuang-Stein, C. PY - 1994 DA - 1994// TI - A new proposal for benefit-less-risk analysis in clinical trials JO - Control Clin Trials VL - 15 UR - https://doi.org/10.1016/0197-2456(94)90026-4 DO - 10.1016/0197-2456(94)90026-4 ID - Chuang-Stein1994 ER - TY - JOUR AU - Osiri, M. AU - Suarez-Almazor, M. E. AU - Wells, G. A. AU - Robinson, V. AU - Tugwell, P. PY - 2003 DA - 2003// TI - Number needed to treat (NNT): implication in rheumatology clinical practice JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.4.316 DO - 10.1136/ard.62.4.316 ID - Osiri2003 ER - TY - JOUR AU - Johnson, F. R. AU - Van Houtven, G. AU - Ozdemir, S. AU - Hass, S. AU - White, J. AU - Francis, G. AU - Miller, D. W. AU - Phillips, J. T. PY - 2009 DA - 2009// TI - Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy JO - J Neurol VL - 256 UR - https://doi.org/10.1007/s00415-009-0084-2 DO - 10.1007/s00415-009-0084-2 ID - Johnson2009 ER - TY - JOUR AU - Ryan, M. AU - McIntosh, E. AU - Shackley, P. PY - 1998 DA - 1998// TI - Methodological issues in the application of conjoint analysis in health care JO - Health Econ VL - 7 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Ryan1998 ER - TY - JOUR AU - Edwards, J. E. AU - McQuay, H. J. AU - Moore, R. A. AU - Collins, S. L. PY - 1999 DA - 1999// TI - Reporting of adverse effects in clinical trials should be improved: lessons from acute postoperative pain JO - J Pain Symptom Manage VL - 18 UR - https://doi.org/10.1016/S0885-3924(99)00093-7 DO - 10.1016/S0885-3924(99)00093-7 ID - Edwards1999 ER - TY - BOOK AU - Lynd, L. AU - Coombes, M. AU - Rishidi, A. AU - Sculpher, M. AU - Willan, A. PY - 2004 DA - 2004// TI - First steps in developing a risk-benefit analysis framework: a systematic review and critical evaluation of risk-benefit analysis methods PB - University of York CY - York (UK) ID - Lynd2004 ER - TY - JOUR AU - Stang, P. E. AU - Pham, S. V. AU - Kinchen, K. AU - Raff, S. B. AU - Mussen, F. AU - Gondek, K. PY - 2008 DA - 2008// TI - The identification of benefit in medical intervention: an overview and suggestions for process JO - Am J Ther VL - 15 UR - https://doi.org/10.1097/MJT.0b013e31816b8fff DO - 10.1097/MJT.0b013e31816b8fff ID - Stang2008 ER - TY - JOUR AU - Puhan, M. A. AU - Chandra, D. AU - Mosenifar, Z. AU - Ries, A. AU - Make, B. AU - Hansel, N. N. AU - Wise, R. A. AU - Sciurba, F. PY - 2011 DA - 2011// TI - The minimal important difference of exercise tests in severe COPD JO - Eur Respir J VL - 37 UR - https://doi.org/10.1183/09031936.00063810 DO - 10.1183/09031936.00063810 ID - Puhan2011 ER - TY - JOUR AU - Puhan, M. A. AU - Frey, M. AU - Buchi, S. AU - Schunemann, H. J. PY - 2008 DA - 2008// TI - The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease JO - Health Qual Life Outcomes VL - 6 UR - https://doi.org/10.1186/1477-7525-6-46 DO - 10.1186/1477-7525-6-46 ID - Puhan2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2288/12/173/prepub UR - http://www.biomedcentral.com/1471-2288/12/173/prepub ID - ref45 ER -